KindlyMD (NASDAQ:NAKA) Coverage Initiated at TD Cowen

Analysts at TD Cowen assumed coverage on shares of KindlyMD (NASDAQ:NAKA) in a research note issued to investors on Friday, Marketbeat reports. The brokerage set a “buy” rating and a $1.00 price target on the stock. TD Cowen’s target price suggests a potential upside of 357.04% from the stock’s current price.

A number of other equities analysts have also recently weighed in on the stock. B. Riley Financial decreased their price objective on shares of KindlyMD from $1.00 to $0.50 and set a “buy” rating for the company in a research report on Monday, February 23rd. Weiss Ratings reissued a “sell (e+)” rating on shares of KindlyMD in a research report on Friday, March 27th. Finally, Maxim Group decreased their price objective on shares of KindlyMD from $1.50 to $0.75 and set a “buy” rating for the company in a research report on Monday, April 6th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $0.75.

KindlyMD Trading Up 3.9%

Shares of NASDAQ NAKA opened at $0.22 on Friday. KindlyMD has a 12-month low of $0.21 and a 12-month high of $34.77. The company has a market cap of $150.98 million, a P/E ratio of -0.25 and a beta of 26.73. The stock has a fifty day moving average price of $0.25 and a 200 day moving average price of $0.49.

Hedge Funds Weigh In On KindlyMD

A number of hedge funds and other institutional investors have recently bought and sold shares of NAKA. Geode Capital Management LLC raised its holdings in shares of KindlyMD by 76.2% during the second quarter. Geode Capital Management LLC now owns 19,394 shares of the company’s stock valued at $484,000 after buying an additional 8,386 shares during the last quarter. Osaic Holdings Inc. bought a new stake in shares of KindlyMD during the second quarter valued at approximately $215,000. Vontobel Holding Ltd. bought a new stake in shares of KindlyMD during the third quarter valued at approximately $335,000. Dynamic Technology Lab Private Ltd bought a new stake in shares of KindlyMD during the third quarter valued at approximately $369,000. Finally, Tower Research Capital LLC TRC raised its holdings in shares of KindlyMD by 1,638.4% during the third quarter. Tower Research Capital LLC TRC now owns 33,152 shares of the company’s stock valued at $827,000 after buying an additional 31,245 shares during the last quarter.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.